MARKET

OGN

OGN

ORGANON & CO
NYSE
15.31
+0.35
+2.34%
After Hours: 15.36 +0.05 +0.33% 19:58 03/14 EDT
OPEN
14.95
PREV CLOSE
14.96
HIGH
15.41
LOW
14.81
VOLUME
3.03M
TURNOVER
--
52 WEEK HIGH
22.29
52 WEEK LOW
13.62
MARKET CAP
3.95B
P/E (TTM)
4.592
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OGN last week (0303-0307)?
Weekly Report · 6d ago
Reported Saturday, Organon's VTAMA Phase 3 Data Shows 84% Of Patients Maintained Mild Disease After 80-Day Off-Treatment Interval In Adults And Children 2+
Benzinga · 6d ago
Barclays Sticks to Its Buy Rating for Organon (OGN)
TipRanks · 6d ago
Organon announes results from analysis of Phase 3 ADORING 3 study
TipRanks · 03/09 22:20
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older
Barchart · 03/08 08:00
Analysts Have Conflicting Sentiments on These Healthcare Companies: Fate Therapeutics (FATE), Organon (OGN) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)
TipRanks · 03/06 10:30
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks
Barchart · 03/04 05:36
Weekly Report: what happened at OGN last week (0224-0228)?
Weekly Report · 03/03 09:09
More
About OGN
Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.

Webull offers Organon & Co stock information, including NYSE: OGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OGN stock methods without spending real money on the virtual paper trading platform.